[1] |
Li X, Ramadori P, Pfister D, et al. The immunological and metabolic landscape in primary and metastatic liver cancer[J]. Nat Rev Cancer, 2021, 21(9): 541-557.
|
[2] |
Wege H, Schulze K, von Felden J, et al. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas[J]. Eur J Med Genet, 2021, 64(11): 104313.
|
[3] |
Altmayer S, Armelin LM, Pereira JS, et al. MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis[J]. Eur Radiol, 2024, 34(1): 106-114.
|
[4] |
Reizine E, Meurgey A, Amaddeo G, et al. Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable[J]. Abdom Radiol(NY), 2022, 47(7): 2347-2355.
|
[5] |
陈倩倩, 芮法娟, 倪文婧, 等. 原发性肝癌的流行病学及其危险因素研究进展[J]. 中国全科医学, 2024, 27(6): 637-642.
|
[6] |
Mandal SK, Yadav P, Sheth RA. The Neuroimmune Axis and Its Therapeutic Potential for Primary Liver Cancer[J]. Int J Mol Sci, 2024, 25(11): 6237.
|
[7] |
张良, 张洪波. 原发性肝癌症状群研究现状[J]. 护理研究, 2024, 38(11): 1982-1986.
|
[8] |
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(6): 385-410.
|
[9] |
Guo X, Tian C, Liu G, et al. Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma[J]. Biotechnol Genet Eng Rev, 2024, 40(1): 623-637.
|
[10] |
Carney BW, Gholami S, Fananapazir G, et al. Utility of combined gadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative detection of colorectal cancer liver metastases: a pilot study[J]. Acta Radiol, 2023, 64(4): 1357-1362.
|
[11] |
邓燕, 段勇. 原发性肝癌发病机制和药物治疗的研究进展[J]. 河北医学, 2024, 30(2): 345-348.
|
[12] |
邹晨, 方淼, 高月求, 等. 靶向Hippo信号通路治疗原发性肝癌的研究进展[J]. 中西医结合肝病杂志, 2024, 34(2): 185-188.
|
[13] |
Yang H, Cheng J, Zhuang H, et al. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer[J]. Cancer Cell, 2024, 42(4): 535-551. e8.
|
[14] |
Görgec B, Hansen IS, Kemmerich G, et al. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial[J]. Lancet Oncol, 2024, 25(1): 137-146.
|
[15] |
陈松, 黄泽和, 李莹, 等. 普美显增强MRI及DWI相关定量参数对原发性肝癌肝脏储备功能及CD34、Glypican-3表达水平的预测价值[J]. 放射学实践, 2023, 38(9): 1134-1139.
|
[16] |
陈松, 黄泽和, 陈家源, 等. 普美显增强MRI多模态定量技术在原发性肝癌患者中的应用[J]. 中国CT和MRI杂志, 2023, 21(4): 150-152.
|
[17] |
Liu J, Ye L, Miao G, et al. Non-enhanced abbreviated MRI as a periodic surveillance protocol for colorectal liver metastases compared with contrast-enhanced CT: a prospective observational study[J]. Int J Surg, 2025, 111(3): 2495-2504.
|
[18] |
Wale A, Harris H, Brown G. Diagnostic Certainty in Characterizing Liver Lesions in Rectal Cancer: Abbreviated Liver MRI versus CT[J]. Ann Surg Oncol, 2025, 32(4): 2435-2445.
|
[19] |
Liu F, Hou B, Li Z, et al. Microwave ablation of multifocal primary liver cancer guided by real-time 3. 0T MRI[J]. Int J Hyperthermia, 2023, 40(1): 2228519.
|
[20] |
Kataoka M, Honda M, Sagawa H, et al. Ultrafast Dynamic Contrast-Enhanced MRI of the Breast: From Theory to Practice[J]. J Magn Reson Imaging, 2024, 60(2): 401-416.
|
[21] |
Chung HJ, Seo N, Han K, et al. Gadoxetic acid-enhanced MRI for the detection of liver metastases from melanoma[J]. PLoS One, 2024, 19(11): e0313212.
|
[22] |
Qu H, Zhang S, Guo M, et al. Deep Learning Model for Predicting Proliferative Hepatocellular Carcinoma Using Dynamic Contrast-Enhanced MRI: Implications for Early Recurrence Prediction Following Radical Resection[J]. Acad Radiol, 2024, 31(11): 4445-4455.
|
[23] |
Marino MA, Avendano D, Sevilimedu V, et al. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors[J]. Eur J Radiol, 2022, 156: 110523.
|
[24] |
蒋启红, 任勇军. 钆塞酸二钠增强MRI在评估肝功能的研究进展[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(2): 183-187.
|
[25] |
Park SH, Heo S, Kim B, et al. Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors[J]. Korean J Radiol, 2023, 24(3): 190-203.
|
[26] |
Jiang H, Qu JR, Wang LF, et al. Hepatobiliary phase manifestations of breast cancer liver metastasis: differentiating molecular types through Gd-EOB-DTPA-enhanced MRI[J]. BMC Med Imaging, 2025, 25(1): 104.
|